Off-Target Effects with Matt Gline
Off-Target Effects with Matt Gline
Podcast Description
Matt shares a biotech CEO's perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.
Podcast Insights
Content Themes
Covers themes including drug development management, market trends, and global biotech impacts, with episodes like the first exploring M&A trends and the influence of China's biotech industry. The podcast delves into critical topics such as investment strategies and operational challenges in the biotech space.
Matt shares a biotech CEO’s perspective on the news, and he interviews other leaders about management topics important to navigating the business of drug development.
Philip Ross talks about the outlook for M&A in our industry, and describes the pharma revenue growth demands that will be driving it. He discusses what qualities make targets attractive, and how the industry has changed over time during the course of his career. Plus, what attracted him to Jefferies.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.